Danish Venture Capital and Private Equity Association

Total investments

3

Average round size

10M

Portfolio companies

3

Lead investments

1

Exits

2

Areas of investment
BiotechnologyOther Pharmaceuticals and BiotechnologySoftwareIndustrialNatural ResourcesDietary SupplementsBiomass Energy

Summary

The company was established in Europe in Denmark. The leading representative office of defined VC is situated in the Copenhagen.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Denmark. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Mondosoft, Fluxome. Among the most successful fund investment fields, there are Natural Resources, Dietary Supplements.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2008. The top amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Danish Venture Capital and Private Equity Association performs on 38 percentage points more the average number of lead investments. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Danish Venture Capital and Private Equity Association, startups are often financed by Vecata, Techno Venture Management, Seventure Partners. The meaningful sponsors for the fund in investment in the same round are Vecata, Techno Venture Management, Seventure Partners. In the next rounds fund is usually obtained by TVM Capital, NRW.BANK, VF Venture.

Show more

Investments analytics

Analytics

Total investments
3
Lead investments
1
Exits
2
Investments by industry
  • Biotechnology (2)
  • Dietary Supplements (1)
  • Natural Resources (1)
  • Software (1)
  • Other Pharmaceuticals and Biotechnology (1)
  • Show 2 more
Investments by region
  • Denmark (1)
  • Germany (1)
  • Romania (1)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
82M
Group Appearance index
1.00
Avg. company exit year
9
Avg. multiplicator
3.29

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
DIREVO Industrial Biotechnology 06 Dec 2002 Biotechnology, Other Pharmaceuticals and Biotechnology, Industrial, Biomass Energy Early Stage Venture 10M Germany, Cologne, North Rhine-Westphalia
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.